Mymedstores

Description:

Mymedstores is a trusted supplier of Osimertinib Tablets, a targeted cancer therapy used for patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). Osimertinib is a third-generation EGFR TKI that has shown proven results in advanced lung cancer therapy.

Key Details:

• Strengths Available: 40mg, 80mg

• Form: Tablet

• Packing: Standard strip / bottle (manufacturer-dependent)

• Indication: Treatment of advanced/metastatic NSCLC with EGFR mutation

• Delivery: Pan-India supply & international export support

• Availability: Retail & bulk orders

Q1: What is Osimertinib used for?

👉 It is prescribed for advanced non-small cell lung cancer (NSCLC) with EGFR mutation.

Q2: What strengths are available?

👉 40mg & 80mg tablets.

Q3: Do you provide generic and brand versions?

👉 Yes, availability depends on stock. Both Indian generics and branded (Tagrisso) can be sourced.

Q4: Do you supply to hospitals and distributors?

👉 Yes, bulk and institutional orders are accepted.

Q5: Do you provide Pan-India delivery?

👉 Yes, including export to multiple countries.

Q6: Do I need a prescription?

👉 Yes, this is a prescription-only cancer medicine.

Why Choose Mymedstores?

✅ Affordable pricing for oncology medicines

✅ Pan-India & global supply chain

✅ Genuine sourcing from authorized manufacturers

✅ Support for hospitals, cancer centers & distributors

📍 Looking for Osimertinib Tablets in Mumbai ? Mymedstores provides genuine cancer medicines at competitive prices with fast delivery.

Note: Osimertinib is a prescription-only medicine. To be used strictly under oncologist supervision.

osimertinib tablets, osimertinib 80mg price, buy osimertinib tablets india, osimertinib suppliers india, tagrisso generic india, lung cancer medicine india, osimertinib exporters india, osimertinib 40mg price, osimertinib tablets delhi, osimertinib tablets mumbai, osimertinib tablets mumbai, tagrisso generic suppliers mumbai, osimertinib 40mg price mumbai

Lanib 250mg Tablet contains the active ingredient lapatinib. It is indicated to treat advanced breast cancer and it may be used alone or in combination with other medications. It is effective against cells sensitive to hormones and rapidly multiplying cancer cells that produce most of the protein called human epidermal growth receptor -2.

The common side effects that are likely to occur while you are on the treatment with Lanib 250mg Tablet are nausea, vomiting, tiredness, weakness, itching, dry skin, loss of appetite, indigestion, constipation, mouth ulcers, stomach pain, difficulty in sleeping, joint or back pain, cough, breathing problems, headache, etc. If you experience severe allergic reactions, skin rashes, heart, liver, and lung problems, report your physician immediately.

BORTETHER 2 INJECTION contains Bortezomib, which belongs to the group of medicines called Antineoplastic agents. It is used in adult patients alone or with pegylated liposomal doxorubicin/dexamethasone to manage progressive multiple myeloma when anticancer therapy or hematopoietic stem cell transplantation becomes unsuitable to manage the disease.

BORTETHER 2 INJECTION is also used in adult patients with rituximab, cyclophosphamide, doxorubicin, and prednisone to manage unmanageed mantle cell lymphoma when hematopoietic stem cell transplantation becomes unsuitable to manage the disease.

Multiple myeloma is a type of cancer that occurs in plasma cells (white blood cells) and is generally characterized by symptoms such as bone pain, nausea, constipation, and loss of appetite. Mantle Cell Lymphoma is a rare form of cancer that affects the lymphatic system and is generally characterized by symptoms such as loss of appetite, fever, nausea, and/or vomiting.